Botswana Blood Products Import Market -- HS Code 3002 Trade Data & Price Trend (Feb 2025)

Botswana Blood Products Import (HS 3002) Key Takeaways

Botswana’s Blood Products Import under HS Code 3002 surged 3.2% in value to $883.20K in February 2025, driven by a 47.7% volume spike as importers prioritized bulk purchases amid new tariff quotas. The market is highly concentrated, with 94.97% of value controlled by a few key suppliers, while South Africa dominates as the primary source, accounting for 49.37% of value and 89.29% of weight. High-value finished goods like immunological products command premium prices ($229.79/unit), signaling trade in specialized, non-commoditized goods. This analysis, covering February 2025, is based on cleanly processed Customs data from the yTrade database.

Botswana Blood Products Import (HS 3002) Background

What is HS Code 3002?

HS Code 3002 covers human and animal blood products, vaccines, toxins, and cultures. These products are critical for healthcare, pharmaceuticals, and biotechnology industries, driving stable global demand due to their essential role in medical treatments and research. Botswana's Blood Products Import under this code reflects its reliance on these materials for public health and veterinary applications.

Current Context and Strategic Position

Under the 2025 trade agreement, Botswana applies annual tariff rate quotas for HS Code 3002 imports from MERCOSUR member states, as outlined in the [BURS tariff notes]. This policy highlights the strategic importance of managing hs code 3002 trade data to ensure supply chain stability and cost efficiency. Botswana's reliance on imported blood products underscores the need for vigilant market monitoring to balance domestic demand with international trade dynamics.

Botswana Blood Products Import (HS 3002) Price Trend

Key Observations

Botswana's imports of Blood Products (HS Code 3002) reached $883.20K USD in February 2025, rising 3.2% from the previous month despite a sharp 30.2% drop in unit price to $42.80/kg. This indicates a significant increase in volume was prioritized over cost during the period.

Price and Volume Dynamics

The Botswana Blood Products Import trend shows a clear strategic shift toward higher volume purchasing, with February's import weight surging 47.7% month-on-month to 20.64K kg. This aggressive volume growth aligns with the implementation of new annual tariff rate quotas for MERCOSUR-sourced goods, as detailed in the national customs schedule [BURS]. The policy likely encouraged stockpiling or forward buying under preferential terms, driving down the average unit cost while boosting the total hs code 3002 value trend. Such movements are typical when importers adjust to new trade agreements that affect critical medical supply chains.

Botswana Blood Products Import (HS 3002) HS Code Breakdown

Product Specialization and Concentration

In February 2025, Botswana's imports under HS Code 3002 are dominated by veterinary vaccines, specifically the sub-code for "Vaccines, toxins, cultures of micro-organisms for veterinary medicine". According to yTrade data, this product accounts for over half of the import value and most of the quantity, with a unit price of 16.05 USD per unit. An extreme price anomaly is present in "Vaccines for human medicine", which has a unit price of only 0.26 USD per unit; this outlier is isolated from the main analysis due to its negligible impact on overall trade.

Value-Chain Structure and Grade Analysis

The non-anomalous imports can be grouped into two main categories based on value-add stage. First, high-value finished goods like "Immunological products in retail packs" command a premium unit price of 229.79 USD per unit, indicating advanced manufacturing. Second, intermediate products such as "Antisera and other blood fractions" have a moderate unit price of 41.99 USD per unit, suggesting a semi-processed stage. This structure points to trade in differentiated manufactured goods rather than fungible commodities, as prices vary widely based on specialization and end-use.

Strategic Implication and Pricing Power

For market players, the high unit prices in finished goods imply strong pricing power for suppliers of specialized items like immunological products. Strategic focus should prioritize sourcing these high-value segments to maximize returns. Analysis of HS Code 3002 trade data reveals that Botswana's import activities are geared towards quality-driven products, requiring attention to supplier reliability and product specifications.

Table: Botswana HS Code 3002) Breakdown Details (Source: yTrade)

Check Detailed HS Code 3002 Breakdown

Botswana Blood Products Import (HS 3002) Origin Countries

Geographic Concentration and Dominant Role

South Africa is the clear leader for Botswana's Blood Products imports in February 2025. It supplied 49.37% of the total import value but an even larger 89.29% of the weight. This gap between the value and weight shares means Botswana primarily sources standard, bulk versions of these goods from its neighbor. South Africa also accounted for over half of all import transactions (52.67%), showing deeply integrated and frequent trade channels.

Origin Countries Clusters and Underlying Causes

The import partners form two distinct clusters. The first is a High-Value Cluster, consisting solely of Ireland. It provided nearly a quarter of the import value (24.80%) from just two shipments with minimal weight, indicating a source for extremely high-cost, specialized blood products. The second is a Diversified Cluster, led by the United States (15.08% value share) and including European nations like Germany and Spain. These countries supply smaller volumes of various blood-related goods, helping Botswana diversify its medical supply sources beyond its dominant partner.

Forward Strategy and Supply Chain Implications

Botswana's blood product supply chain is highly dependent on South Africa for bulk needs. This creates a risk if there are any disruptions to cross-border trade or production in South Africa. The strategy should focus on maintaining this efficient supply route for cost-effective goods while using partners like Ireland and the US for critical, high-specification products that are not available locally or regionally. This balanced approach ensures a stable supply of both common and specialized medical necessities.

Table: Botswana Blood Products (HS 3002) Top Origin Countries (Source: yTrade)

Get Complete Origin Countries Profile

Botswana Blood Products (HS 3002) Suppliers Analysis

Supplier Concentration and Dominance

According to yTrade data, the Botswana Blood Products Import supplier market in February 2025 was highly concentrated. The typical trade was dominated by a small group of high-value, high-frequency suppliers. This group accounted for 94.97% of the total import value, handling nearly all the volume and value.

Strategic Supplier Clusters and Trade Role

The profile of HS code 3002 suppliers indicates a direct-to-factory sourcing model, with manufacturers like ONDERSTEPOORT BIOLOGICAL PRODUCTS and MSD serving as the primary partners. A secondary cluster of lower-value but frequent suppliers, including MEDPET PTY LTD and BIO-RAD LABORATORIES, INC, provided supplementary goods, representing just over 5% of the value. No low-frequency suppliers were active during this period.

Sourcing Strategy and Vulnerability

Botswana's sourcing strategy relies heavily on a few key manufacturers, creating potential supply chain risk if disruptions affect these partners. The high concentration means importers should monitor these relationships closely and consider developing alternative sources for critical blood products. The current model is efficient but lacks diversification, which could impact supply stability during unforeseen events.

Table: Botswana Blood Products (HS 3002) Top Suppliers List (Source: yTrade)

Check Full Blood Products Supplier lists

Action Plan for Blood Products Market Operation and Expansion

• Use hs code 3002 trade data to identify and qualify secondary suppliers for high-value immunological products, mitigating the risk from Botswana's concentrated Blood Products supply chain and ensuring a stable supply of critical medical goods.
• Negotiate pricing for bulk antisera and blood fractions by benchmarking against the unit prices revealed in the import data, securing better terms from South African partners and lowering the overall cost of the Botswana Blood Products Import.
• Monitor shipments from high-value partners like Ireland in real-time, as their specialized, low-volume consignments represent a significant portion of the import value and require careful logistics management to avoid costly delays.
• Develop a contingency plan for the Botswana Blood Products supply chain that prioritizes air freight routes for critical high-specification goods from diversified partners, ensuring uninterrupted access to lifesaving products during regional trade disruptions.

Take Action Now —— Explore Botswana Blood Products Import Data

Frequently Asked Questions

Q1. What is driving the recent changes in Botswana Blood Products Import 2025 February?

Botswana's imports surged 47.7% in volume while unit prices dropped 30.2%, likely due to stockpiling under new MERCOSUR tariff quotas for cost-effective bulk medical supplies.

Q2. Who are the main origin countries of Botswana Blood Products (HS Code 3002) 2025 February?

South Africa dominates with 49.37% of import value, followed by Ireland (24.80%) and the United States (15.08%), forming distinct bulk and high-value supply clusters.

Q3. Why does the unit price differ across origin countries of Botswana Blood Products Import?

Prices vary by product grade: South Africa supplies bulk veterinary vaccines at $16.05/unit, while Ireland provides high-end immunological products at $229.79/unit.

Q4. What should importers in Botswana focus on when buying Blood Products?

Prioritize sourcing high-value finished goods like immunological products while maintaining South Africa for bulk needs, but diversify suppliers to mitigate concentration risks.

Q5. What does this Botswana Blood Products import pattern mean for overseas suppliers?

Suppliers of specialized products (e.g., Ireland) have pricing power, while bulk providers (e.g., South Africa) must compete on volume efficiency given Botswana's tariff-driven stockpiling.

Q6. How is Blood Products typically used in this trade flow?

Imports are primarily veterinary vaccines and human medical products, with high-value items like antisera and immunological goods used for advanced healthcare applications.